Literature DB >> 17235395

Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

Nelly Pitteloud1, Richard Quinton, Simon Pearce, Taneli Raivio, James Acierno, Andrew Dwyer, Lacey Plummer, Virginia Hughes, Stephanie Seminara, Yu-Zhu Cheng, Wei-Ping Li, Gavin Maccoll, Anna V Eliseenkova, Shaun K Olsen, Omar A Ibrahimi, Frances J Hayes, Paul Boepple, Janet E Hall, Pierre Bouloux, Moosa Mohammadi, William Crowley.   

Abstract

Idiopathic hypogonadotropic hypogonadism (IHH) due to defects of gonadotropin-releasing hormone (GnRH) secretion and/or action is a developmental disorder of sexual maturation. To date, several single-gene defects have been implicated in the pathogenesis of IHH. However, significant inter- and intrafamilial variability and apparent incomplete penetrance in familial cases of IHH are difficult to reconcile with the model of a single-gene defect. We therefore hypothesized that mutations at different IHH loci interact in some families to modify their phenotypes. To address this issue, we studied 2 families, one with Kallmann syndrome (IHH and anosmia) and another with normosmic IHH, in which a single-gene defect had been identified: a heterozygous FGF receptor 1 (FGFR1) mutation in pedigree 1 and a compound heterozygous gonadotropin-releasing hormone receptor (GNRHR) mutation in pedigree 2, both of which varied markedly in expressivity within and across families. Further candidate gene screening revealed a second heterozygous deletion in the nasal embryonic LHRH factor (NELF) gene in pedigree 1 and an additional heterozygous FGFR1 mutation in pedigree 2 that accounted for the considerable phenotypic variability. Therefore, 2 different gene defects can synergize to produce a more severe phenotype in IHH families than either alone. This genetic model could account for some phenotypic heterogeneity seen in GnRH deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235395      PMCID: PMC1765517          DOI: 10.1172/JCI29884

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).

Authors:  Delphine Zenaty; Patricia Bretones; Cécile Lambe; Isabelle Guemas; Michel David; Juliane Léger; Nicolas de Roux
Journal:  Mol Cell Endocrinol       Date:  2006-06-06       Impact factor: 4.102

2.  Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.

Authors:  S E Antonarakis
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.

Authors:  M Mohammadi; J Schlessinger; S R Hubbard
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

4.  A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.

Authors:  N de Roux; J Young; M Misrahi; R Genet; P Chanson; G Schaison; E Milgrom
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

5.  An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination.

Authors:  E N Meyers; M Lewandoski; G R Martin
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction.

Authors:  M Mohammadi; I Dikic; A Sorokin; W H Burgess; M Jaye; J Schlessinger
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors.

Authors:  G B Vannelli; F Ensoli; R Zonefrati; Y Kubota; A Arcangeli; A Becchetti; G Camici; T Barni; C J Thiele; G C Balboni
Journal:  J Neurosci       Date:  1995-06       Impact factor: 6.167

8.  The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred.

Authors:  N de Roux; J Young; S Brailly-Tabard; M Misrahi; E Milgrom; G Schaison
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

9.  The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif.

Authors:  E P Newberry; J M Boudreaux; D A Towler
Journal:  Mol Endocrinol       Date:  1996-08

10.  Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.

Authors:  David González-Martínez; Soo-Hyun Kim; Youli Hu; Scott Guimond; Jonathan Schofield; Paul Winyard; Gabriella Barbara Vannelli; Jeremy Turnbull; Pierre-Marc Bouloux
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

View more
  164 in total

Review 1.  Signaling of cytokines is important in regulation of GnRH neurons.

Authors:  Sheng Wu; Andrew Wolfe
Journal:  Mol Neurobiol       Date:  2011-12-13       Impact factor: 5.590

2.  Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.

Authors:  T-S Jap; C-Y Chiu; J-F Lirng; G-S Won
Journal:  J Endocrinol Invest       Date:  2010-06-04       Impact factor: 4.256

3.  Commentary: the year in endocrine genetics for basic scientists.

Authors:  William F Crowley
Journal:  Mol Endocrinol       Date:  2011-11-22

Review 4.  Deciphering genetic disease in the genomic era: the model of GnRH deficiency.

Authors:  Gerasimos P Sykiotis; Nelly Pitteloud; Stephanie B Seminara; Ursula B Kaiser; William F Crowley
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

5.  An ancient founder mutation in PROKR2 impairs human reproduction.

Authors:  Magdalena Avbelj Stefanija; Marc Jeanpierre; Gerasimos P Sykiotis; Jacques Young; Richard Quinton; Ana Paula Abreu; Lacey Plummer; Margaret G Au; Ravikumar Balasubramanian; Andrew A Dwyer; Jose C Florez; Timothy Cheetham; Simon H Pearce; Radhika Purushothaman; Albert Schinzel; Michel Pugeat; Elka E Jacobson-Dickman; Svetlana Ten; Ana Claudia Latronico; James F Gusella; Catherine Dode; William F Crowley; Nelly Pitteloud
Journal:  Hum Mol Genet       Date:  2012-07-05       Impact factor: 6.150

6.  Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis.

Authors:  Andrew O M Wilkie; Jo C Byren; Jane A Hurst; Jayaratnam Jayamohan; David Johnson; Samantha J L Knight; Tracy Lester; Peter G Richards; Stephen R F Twigg; Steven A Wall
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

Review 7.  From nose to brain: development of gonadotrophin-releasing hormone-1 neurones.

Authors:  S Wray
Journal:  J Neuroendocrinol       Date:  2010-07       Impact factor: 3.627

Review 8.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

9.  Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic central pubertal disorders.

Authors:  Cintia Tusset; Sekoni D Noel; Ericka B Trarbach; Letícia F G Silveira; Alexander A L Jorge; Vinicius N Brito; Priscila Cukier; Stephanie B Seminara; Berenice B de Mendonça; Ursula B Kaiser; Ana Claudia Latronico
Journal:  Arq Bras Endocrinol Metabol       Date:  2012-12

Review 10.  The genetic basis of female reproductive disorders: etiology and clinical testing.

Authors:  Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.